Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2016 /
Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors

16th - 20th Apr 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.05.16
Views: 1354
Rating:

Dr Shivaani Kummar - Stanford University, Stanford, USA

Dr Shivaani Kummar speaks with ecancertv at AACR 2016 about cell cycle regulation by checkpoint inhibitors.

By utilising the same checkpoint mechanisms that prevent damaged cells from replicating to limit tumour growth and stimulate host immunity, Dr Kummar describes the clinical significance of targeting Wee1 kinase pathways.

With trials of combination therapies and single agents now entering phase II, she also reports on the toxic side effects and risks of adjacent cytotoxic therapies.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation